Liquid Genomics
2013
FOUNDED
M&A
STATUS
1-10
EMPLOYEES
M&A
LATEST DEAL TYPE
$7.24M
LATEST DEAL AMOUNT
Description
Provider of blood-based biomarker intended to be used for tumor profiling. The company's blood-based biomarker utilizes non-invasive blood-based molecular testing methods enabling cancer patients to assess gene mutations, expressions, and fusions to inform treatment strategies for chemotherapy.
Primary Office
- 9920 Jefferson Boulevard
- Culver City, CA 90501
- United States
+1 (310) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Liquid Genomics’s full profile, request a free trial.
Liquid Genomics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 31-Mar-2017 | $7.24M | 00.000 | 00.000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 18-Jan-2017 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 28-Mar-2016 | $3.24M | $3.24M | 00.000 | Completed | Generating Revenue |
Liquid Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Liquid Genomics Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Kathleen Danenberg | Co-Founder, Board Member, President & Chief Executive Officer |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »